HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

What's new in the management of chronic primary immune thrombocytopenia in adults and the use of thrombopoietin receptor agonists.

AuthorsAdrian Newland
JournalMedical principles and practice : international journal of the Kuwait University, Health Science Centre (Med Princ Pract) Vol. 20 Issue 4 Pg. 301-2 ( 2011) ISSN: 1423-0151 [Electronic] Switzerland
PMID21576988 (Publication Type: Journal Article)
Chemical References
  • Receptors, Thrombopoietin
  • Recombinant Proteins
  • polyethylene glycol-recombinant human megakaryocyte growth and development factor
  • Polyethylene Glycols
  • Thrombopoietin
Topics
  • Chronic Disease
  • Humans
  • Platelet Count
  • Polyethylene Glycols (therapeutic use)
  • Purpura, Thrombocytopenic, Idiopathic (diagnosis, drug therapy, surgery)
  • Receptors, Thrombopoietin (agonists, metabolism)
  • Recombinant Proteins (therapeutic use)
  • Risk Factors
  • Splenectomy
  • Thrombopoietin (therapeutic use)
  • Treatment Failure

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: